Blood Res.  2014 Sep;49(3):139-140. 10.5045/br.2014.49.3.139.

Way to go to exploit NK cells' versatile talents for cancer immunotherapy

• Cho D

• KMID: 2172780
• DOI: http://doi.org/10.5045/br.2014.49.3.139

Abstract

No abstract available.

MeSH Terms

Aptitude*
Immunotherapy*

Reference

1. Caligiuri MA. Human natural killer cells. Blood. 2008; 112:461–469. PMID: 18650461.

2. NK cell expansion. Kuerten, Germany: NKcells.info;2014. Accessed September 19, 2014. at http://www.nkcells.info/index.php?title=NK_cell_expansion.

3. Cho D, Campana D. Expansion and activation of natural killer cells for cancer immunotherapy. Korean J Lab Med. 2009; 29:89–96. PMID: 19411773.

4. Lim SA, Kim TJ, Lee JE, et al. Ex vivo expansion of highly cytotoxic human NK cells by cocultivation with irradiated tumor cells for adoptive immunotherapy. Cancer Res. 2013; 73:2598–2607. PMID: 23580577.

5. Denman CJ, Senyukov VV, Somanchi SS, et al. Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells. PLoS One. 2012; 7:e30264. PMID: 22279576.

6. Bae DS, Lee JK. Development of NK cell expansion methods using feeder cells from human myelogenous leukemia cell line. Blood Res. 2014; 49:154–161.

7. Kim JK, Chung JS, Shin HJ, et al. Influence of NK cell count on the survival of patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood Res. 2014; 49:162–169.

8. Song MK, Chung JS, Seol YM, et al. Influence of low absolute lymphocyte count of patients with nongerminal center type diffuse large B-cell lymphoma with R-CHOP therapy. Ann Oncol. 2010; 21:140–144. PMID: 19887468.

9. Hurvitz SA, Betting DJ, Stern HM, et al. Analysis of Fcγ receptor IIIa and IIa polymorphisms: lack of correlation with outcome in trastuzumab-treated breast cancer patients. Clin Cancer Res. 2012; 18:3478–3486. PMID: 22504044.

10. Bekaii-Saab TS, Roda JM, Guenterberg KD, et al. A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies. Mol Cancer Ther. 2009; 8:2983–2991. PMID: 19887543.